Notably, c-KIT activation induces the upregulation of TRIM21 expression but the downregulation of USP15 expression, which destabilizes ACSL4 and is associated with the resistance of GIST to imatinib (a c-KIT inhibitor) 94. The gene discussed is KIT; the disease is gastrointestinal stromal tumor.